Medroxyprogesterone Acetate Injection Suspension

Medroxyprogesterone Acetate Injection Suspension

  • Packing: 1 Ml Vial, 1 ml PFS
  • Available Strength : 150 Mg/Ml

Description

Product Description: Medroxyprogesterone Acetate Injection Suspension is a hormonal medication containing medroxyprogesterone acetate, a synthetic form of the hormone progesterone. It is formulated as a suspension for injection and is used for various therapeutic and reproductive health purposes.

Indications and Usage: Medroxyprogesterone Acetate Injection Suspension is indicated for the treatment of abnormal uterine bleeding due to hormonal imbalance, amenorrhea, endometriosis, and as a contraceptive agent. It may also be used in combination with estrogen therapy for hormone replacement therapy (HRT) in postmenopausal women.

Dosage and Administration: The dosage of Medroxyprogesterone Acetate Injection Suspension varies depending on the indication and individual patient factors. It is typically administered via intramuscular or subcutaneous injection according to a prescribed dosing schedule determined by a healthcare provider.

Dosage Forms and Strengths: Medroxyprogesterone Acetate Injection Suspension is available as a sterile suspension in vials or pre-filled syringes. Each milliliter of suspension contains a specific amount of medroxyprogesterone acetate, typically ranging from 50 mg/mL to 150 mg/mL.

Contraindications: Medroxyprogesterone Acetate Injection Suspension is contraindicated in pregnant women, women with a history of breast cancer, liver dysfunction, thromboembolic disorders, and hypersensitivity to medroxyprogesterone acetate or any of the components of the formulation.

Warnings and Precautions: Before initiating therapy with Medroxyprogesterone Acetate Injection Suspension, healthcare providers should evaluate patients for cardiovascular risk factors, including hypertension, diabetes, and smoking. Patients should be monitored regularly for signs of thromboembolic events, breast abnormalities, and other adverse effects associated with progestin therapy.

Adverse Reactions/Side Effects: Common adverse reactions associated with Medroxyprogesterone Acetate Injection Suspension include menstrual irregularities, weight gain, breast tenderness, headache, and mood changes. Other potential side effects may include nausea, bloating, and allergic reactions.

Drug Interactions: Medroxyprogesterone Acetate Injection Suspension may interact with other medications, including corticosteroids, anticonvulsants, anticoagulants, and herbal supplements. Healthcare providers should carefully evaluate patients for potential drug interactions before initiating therapy.

Use In Specific Populations Description: Medroxyprogesterone Acetate Injection Suspension is not recommended for use in pregnant women or women who are breastfeeding. It should be used with caution in women with a history of cardiovascular disease, liver dysfunction, or other medical conditions that may increase the risk of adverse effects.

How Supplied/Storage and Handling: Medroxyprogesterone Acetate Injection Suspension is supplied as a sterile suspension in vials or pre-filled syringes. It should be stored at controlled room temperature, protected from light and moisture. Unused portions should be discarded according to local regulations for biohazardous waste disposal.